RSC acquires rights to Merck Index


The Royal Society of Chemistry (RSC) has acquired the rights to the ‘bible’ of chemistry, the Merck Index, familiar around the world to medicinal chemists and drug discovery scientists. The society will be responsible for publishing the 15th edition of the iconic red tome, which bills itself as ‘chemistry’s constant companion’. The organisation also has plans to make the index more accessible and expand its online presence.

To date, the Merck Index has sold more than 1 million copies around the world over its 123-year lifespan. The index contains a whole host of chemical structures and information on small molecule and biological drugs, environmentally important compounds and industrial and speciality chemicals, for example. The current edition also contains more than 10,000 monographs and 450 named organic reactions.

‘We are very excited to be welcoming a title as prestigious as the Merck Index to the RSC portfolio,’ said James Milne, RSC publishing executive director. ‘It makes an excellent strategic fit with our current publishing activities, complementing existing services such as ChemSpider, the award-winning free database of chemical structures.’

Derek Lowe, a medicinal chemist and regular columnist for Chemistry World, says that he thinks the RSC has got the right idea by expanding the index’s online offering. However, he notes that any upgraded index will be battling against other online sources, such as Wikipedia, and will have to work hard to make a name for itself on the internet.


Related Content

Merck KGaA to buy Sigma–Aldrich

26 September 2014 Business

news image

$17bn acquisition expands Merck’s life science business and US presence, but it isn’t stepping back from drug development

End of the road for h-index rankings

27 November 2012 News and Analysis

news image

Criticism leads US group to stop collating ranked list of living chemists

Most Read

Sun rises on new solar route to hydrogen

27 February 2015 Research

news image

Photocatalyst has solar-to-hydrogen conversion efficiency of 2% and points way to cheap production of the gas

The mothers of invention

24 February 2015 Managing Change

news image

Nina Notman profiles four researchers successfully balancing an academic career with family life

Most Commented

Sun rises on new solar route to hydrogen

27 February 2015 Research

news image

Photocatalyst has solar-to-hydrogen conversion efficiency of 2% and points way to cheap production of the gas

Hepatitis C drug patent challenged in Europe

19 February 2015 Business

news image

Campaign group says Gilead’s expensive blockbuster sofosbuvir is not innovative enough to warrant a patent